Minimally invasive cerebral revascularization in moyamoya disease in adult patients

• Published in: Neuro-chirurgie 2022-10, Vol.68 (5), p.493-497
• Main Authors: Lopez-Gonzalez, M.A., Eastin, M., Woo, M., Ramanathan, D., Gospodarev, V., Wilson, T., Zarabi, H., Sharafeddin, F.
• Format: Article
• Language: English
• Subjects: Bypass; Cerebral revascularization; Minimal invasive; Moyamoya disease
• ISSN: 0028-3770; 1773-0619
• DOI: 10.1016/j.neuchi.2022.03.007

Moyamoya disease (MMD) affects young patients, is generally progressive, and results in strokes or cerebral hemorrhages for which medical management is not effective. To determine the effectiveness of surgical management with minimally invasive cerebral revascularization in MMD. We conducted a retrospective cohort study of patients undergoing extracranial-intracranial microsurgical revascularization surgery with mini-craniotomy, analyzing the epidemiological, clinical, neuroimaging, postoperative evolution, and complications. We describe the technique in detail. Key outcomes included graft patency, complications, and recurrence of ischemic or hemorrhagic stroke. From September 2017 to December 2020, 12 brain revascularization procedures for MMD were performed in eight patients (four bilateral), and all 12 grafts were classified as patent. The main complication was contralateral cerebral infarction identified by postoperative neuroimaging in a patient without clinical symptomatology. There was no case of scalp ischemia or necrosis when performing the minimally invasive approach with linear incision. The results of this study suggest that the minimally invasive extracranial-intracranial cerebral revascularization procedure for MMD in adults is effective, with graft patency in all cases and minimal morbidity.